Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Heart valve tissue engineering: concepts, approaches, progress, and challenges.

Karen Mendelson¹, Frederick J Schoen

¹Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Annals of Biomedical Engineering

|October 21, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endogenous tissue restoration in a hemodialysis conduit: Performance and safety after 1-year of follow-up.

The journal of vascular access·2025

Same author

The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses.

Frontiers in immunology·2025

Same author

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.

Annals of thoracic surgery short reports·2025

Same author

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes.

Innovations (Philadelphia, Pa.)·2025

Same author

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.

JACC. Advances·2025

Same author

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.

Circulation. Cardiovascular quality and outcomes·2025

Tissue engineering aims to create functional heart valves using various scaffold and cell strategies. Significant challenges remain in clinical translation for regenerative medicine applications.

Area of Science:

Regenerative Medicine
Biomedical Engineering
Cardiovascular Research

Background:

Heart valve disease affects millions globally, necessitating advanced treatment options.
Current treatments like mechanical or biological valves have limitations.
Tissue engineering offers a promising alternative for creating functional heart valve replacements.

Purpose of the Study:

To review the fundamental principles and approaches in tissue engineering for heart valve regeneration.
To discuss the progress, challenges, and future directions in developing engineered tissue heart valves.
To provide a framework for understanding the biological and engineering aspects of heart valve tissue engineering.

Main Methods:

Examination of normal heart valve structure, biomechanics, development, and response to injury.

Related Experiment Videos

Analysis of three primary tissue engineering approaches: synthetic scaffolds, tissue scaffolds, and in-vivo cell recruitment.

Review of advancements in biodegradable polymers, cellular manipulation, and extracellular matrix regeneration.

Main Results:

Tissue engineering of heart valves faces unique biological and engineering hurdles.
Three main strategies are being explored for engineered heart valve development.
Modest progress has been made, but clinical application requires further advancements.

Conclusions:

Successful clinical translation of engineered heart valves requires overcoming significant challenges.
Future research must focus on scaffold materials, cell therapies, and in vivo assessment methods.
Continued innovation in tissue engineering is crucial for advancing regenerative medicine in cardiology.